Clinical Trial Update: Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML

View source ↗

Summary

A ClinicalTrials.gov entry reports an ongoing study investigating how gut microbiota interacts with tyrosine kinase inhibitors to influence outcomes in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Carmen Fava | Conditions: Leukemia,Myeloid, Chronic | Status: RECRUITING